is mounjaro a glp 1 drugs GLP-1 receptor agonists Semaglutide vs. Other GLP-1 Receptor

There is evidence that ipragliflozin has favorable metabolic effects that include improved glycemic control and decreased blood pressure (BP), body weight (BW), and visceral adipose tissue, changes that indicate a potential cardiovascular protective effect [3]

Dias V, Junn E, Mouradian MM

When other receptor antagonists are administered, a compensatory increase in the circulating hormone levels is seen (115)

( 10.1056/NEJMoa1509225) [DOI] [PubMed] [Google Scholar] 108.Marso SP, Daniels GH, Frandsen KB, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LSet al

Without clinical data, effectiveness remains largely unproven outside of anecdotal data

And so often what we may find is that patients may not feel as thirsty.Dr